Filing Details

Accession Number:
0001562180-24-001988
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-29 16:38:56
Reporting Period:
2024-02-27
Accepted Time:
2024-02-29 16:38:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645113 Novocure Ltd NVCR Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1822879 X Frank Leonard C/O Novocure Inc.
1550 Liberty Ridge Drive, Suite 115
Wayne PA 19087
Evp, Pres., Novocure Oncology No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2024-02-27 102,249 $16.30 164,695 No 4 A Direct
Ordinary Shares Disposition 2024-02-28 2,078 $16.14 162,617 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Options (Right to buy) Acquisiton 2024-02-27 156,348 $16.30 156,348 $16.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
156,348 2025-02-27 2034-02-26 No 4 A Direct
Footnotes
  1. Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
  2. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  3. Options to buy 156,348 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.